Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy

DG Wilkinson, PT Francis, E Schwam, J Payne-Parrish - Drugs & aging, 2004 - Springer
The deficiency in cholinergic neurotransmission in Alzheimer's disease has led to the
development of cholinesterase inhibitors as the first-line treatment for symptoms of this …

[引用][C] Cholinesterase Inhibitors Used in the Treatment of Alzheimer??? s Disease

DG Wilkinson, PT Francis, E Schwam, J Payne-Parrish - Drugs & Aging, 2004 - cir.nii.ac.jp
Cholinesterase Inhibitors Used in the Treatment of Alzheimer???s Disease | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

[引用][C] Cholinesterase inhibitors used in the treatment of Alzheimer's disease: The relationship between pharmacological effects and clinical efficacy

DG WILKINSON, PT FRANCIS, E SCHWAM… - Drugs & …, 2004 - pascal-francis.inist.fr
Cholinesterase inhibitors used in the treatment of Alzheimer's disease: The relationship
between pharmacological effects and clinical efficacy CNRS Inist Pascal-Francis CNRS …

[PDF][PDF] Cholinesterase Inhibitors Used in the Treatment of Alzheimer's Disease

DG Wilkinson, PT Francis, E Schwam, J Payne-Parrish - Drugs, 2004 - researchgate.net
Abstract led to the development of cholinesterase inhibitors as the first-line treatment for
symptoms of this disease. The clinical benefits of these agents include improvements …

Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy

DG Wilkinson, PT Francis, E Schwam… - Drugs & Aging, 2004 - go.gale.com
The deficiency in cholinergic neurotransmission in Alzheimer's disease has led to the
development of cholinesterase inhibitors as the first-line treatment for symptoms of this …

Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.

DG Wilkinson, PT Francis, E Schwam… - Drugs & Aging, 2004 - europepmc.org
The deficiency in cholinergic neurotransmission in Alzheimer's disease has led to the
development of cholinesterase inhibitors as the first-line treatment for symptoms of this …

Cholinesterase inhibitors used in the treatment of Alzheimer's disease the relationship between pharmacological effects and clinical efficacy

DG Wilkinson, PT Francis, E Schwam… - Drugs and …, 2004 - kclpure.kcl.ac.uk
The deficiency in cholinergic neurotransmission in Alzheimer's disease has led to the
development of cholinesterase inhibitors as the first-line treatment for symptoms of this …

Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy

DG Wilkinson, PT Francis, E Schwam… - Drugs & …, 2004 - pubmed.ncbi.nlm.nih.gov
The deficiency in cholinergic neurotransmission in Alzheimer's disease has led to the
development of cholinesterase inhibitors as the first-line treatment for symptoms of this …

Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.

DG Wilkinson, PT Francis, E Schwam… - Drugs & …, 2004 - search.ebscohost.com
The deficiency in cholinergic neurotransmission in Alzheimer's disease has led to the
development of cholinesterase inhibitors as the first-line treatment for symptoms of this …

[PDF][PDF] Cholinesterase Inhibitors Used in the Treatment of Alzheimer's Disease

DG Wilkinson, PT Francis, E Schwam, J Payne-Parrish - Drugs, 2004 - researchgate.net
Abstract led to the development of cholinesterase inhibitors as the first-line treatment for
symptoms of this disease. The clinical benefits of these agents include improvements …